Fund profile by ISIN IE00036F4K40
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C USD
Research Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C USD by ISIN IE00036F4K40: TER 0.35%, domicile Ireland, and 1-year price performance +17.0%.
ISINIE00036F4K40
TER0.35%
DomicileIreland
Distribution policy—
Index—
Fund size27M
Holdings—
1-year price performance+17.0%
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| XDG3.DE | XETRADefault at German brokers | EUR | Ireland | €18K | 553 |
| XDG3.MI | ETFP | EUR | Ireland | €14K | 429 |
| SDG3.L | LSE | GBP | Ireland | €4K | 132 |
| XDG3.L | LSE | USD | Ireland | €1K | 40 |
| XDG3.SW | SW | CHF | Ireland | €266 | 9 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund trades on a German exchange. As of 2026-08-28.
Largest holdings
The 10 largest holdings make up 45.48% of the fund. As of 2026-08-14.
| Holding | Symbol | Weight |
|---|---|---|
| AbbVie Inc | ABBV | 4.92% |
| Eli Lilly and Co | LLY | 4.91% |
| Danaher Corp | DHR | 4.77% |
| Merck & Co Inc | MRK | 4.70% |
| Thermo Fisher Scientific Inc | TMO | 4.68% |
| Johnson & Johnson | JNJ | 4.62% |
| Amgen Inc | AMGN | 4.46% |
| AstraZeneca PLC | AZN.L | 4.21% |
| Stryker Corp | SYK | 4.14% |
| Vertex Pharmaceuticals Inc | VRTX | 4.07% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.